Cargando…

Molecular Basis for Endocrine Disruption by Pesticides Targeting Aromatase and Estrogen Receptor

The intensive use of pesticides has led to their increasing presence in water, soil, and agricultural products. Mounting evidence indicates that some pesticides may be endocrine disrupting chemicals (EDCs), being therefore harmful for the human health and the environment. In this study, three pestic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chao, Schilirò, Tiziana, Gea, Marta, Bianchi, Silvia, Spinello, Angelo, Magistrato, Alessandra, Gilardi, Gianfranco, Di Nardo, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459580/ https://www.ncbi.nlm.nih.gov/pubmed/32764486 http://dx.doi.org/10.3390/ijerph17165664

Ejemplares similares

Assessment of Five Pesticides as Endocrine-Disrupting Chemicals: Effects on Estrogen Receptors and Aromatase
por: Gea, Marta, et al.
Publicado: (2022)

Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment
por: Gobbi, Silvia, et al.
Publicado: (2023)

Molecular and Structural Evolution of Cytochrome P450 Aromatase
por: Di Nardo, Giovanna, et al.
Publicado: (2021)

Depicting the proton relay network in human aromatase: New insights into the role of the alcohol‐acid pair
por: Zhang, Chao, et al.
Publicado: (2022)

Oestrogenic Activity in Girls with Signs of Precocious Puberty as Exposure Biomarker to Endocrine Disrupting Chemicals: A Pilot Study
por: Gea, Marta, et al.
Publicado: (2022)

A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers
por: Pavlin, Matic, et al.
Publicado: (2018)

Polymorphism on human aromatase affects protein dynamics and substrate binding: spectroscopic evidence
por: Di Nardo, Giovanna, et al.
Publicado: (2021)

Dynamics and Flexibility of Human Aromatase Probed by FTIR and Time Resolved Fluorescence Spectroscopy
por: Di Nardo, Giovanna, et al.
Publicado: (2013)

Structural, Thermodynamic, and Kinetic Traits of Antiestrogen-Compounds Selectively Targeting the Y537S Mutant Estrogen Receptor α Transcriptional Activity in Breast Cancer Cell Lines
por: Pavlin, Matic, et al.
Publicado: (2019)

Investigating the Molecular Mechanism of H3B-8800: A Splicing Modulator Inducing Preferential Lethality in Spliceosome-Mutant Cancers
por: Spinello, Angelo, et al.
Publicado: (2021)

Unexamined Endocrine Disruption? Pesticides Inhibit Prostaglandin Activity
por: Konkel, Lindsey
Publicado: (2016)

Toxicity and Estrogenic Endocrine Disrupting Activity of Phthalates and Their Mixtures
por: Chen, Xueping, et al.
Publicado: (2014)

The Aromatase–Estrogen System in the Testes of Non-Mammalian Vertebrates
por: Rosati, Luigi, et al.
Publicado: (2021)

Modelling inhibition of avian aromatase by azole pesticides
por: Saxena, A.K., et al.
Publicado: (2015)

Pesticide Mixtures, Endocrine Disruption, and Amphibian Declines: Are We Underestimating the Impact?
por: Hayes, Tyrone B., et al.
Publicado: (2006)

Analysis of Endocrine Disrupting Pesticides by Capillary GC with Mass Spectrometric Detection
por: Matisová, Eva, et al.
Publicado: (2012)

Toxicological Mechanism of Endocrine Disrupting Chemicals:Is Estrogen Receptor Involved?
por: Jeung, Eui-Bae, et al.
Publicado: (2010)

Estrogenic Pastures: A Source of Endocrine Disruption in Sheep Reproduction
por: Pool, Kelsey R., et al.
Publicado: (2022)

Editorial: Estrogen receptors in endocrine disorders
por: Filardi, Tiziana, et al.
Publicado: (2023)

Atrazine-Induced Aromatase Expression Is SF-1 Dependent: Implications for Endocrine Disruption in Wildlife and Reproductive Cancers in Humans
por: Fan, WuQiang, et al.
Publicado: (2007)

Peer review of the pesticide risk assessment of the potential endocrine disrupting properties of glyphosate
Publicado: (2017)

Endocrine-Disrupting Organochlorine Pesticides in Human Breast Milk: Changes during Lactation
por: Witczak, Agata, et al.
Publicado: (2021)

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer
por: Lykkesfeldt, Anne E, et al.
Publicado: (2009)

Optimization of the Bacterial Cytochrome P450 BM3 System for the Production of Human Drug Metabolites
por: Di Nardo, Giovanna, et al.
Publicado: (2012)

Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.
por: Kao, Y C, et al.
Publicado: (1998)

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds
por: Harada, Shusaku, et al.
Publicado: (2015)

Assessment and Molecular Actions of Endocrine-Disrupting Chemicals That Interfere with Estrogen Receptor Pathways
por: Kerdivel, Gwenneg, et al.
Publicado: (2013)

Research Advances in the Analysis of Estrogenic Endocrine Disrupting Compounds in Milk and Dairy Products
por: Chang, Jia, et al.
Publicado: (2022)

Peer review of the pesticide risk assessment for the active substance flutianil in light of confirmatory data on the endocrine disruption assessment
por: Alvarez, Fernando, et al.
Publicado: (2022)

Peer review of the pesticide risk assessment of the active substance S‐metolachlor excluding the assessment of the endocrine disrupting properties
por: Alvarez, Fernando, et al.
Publicado: (2023)

Aromatase expression and role of estrogens in male gonad : a review
por: Carreau, Serge, et al.
Publicado: (2003)

Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification
por: La Merrill, Michele A., et al.
Publicado: (2019)

Commentary: “Estrogenic and Anti-Androgenic Endocrine Disrupting Chemicals and Their Impact on the Male Reproductive System”
por: Paumgartten, Francisco José Roma
Publicado: (2015)

Label-Free Biosensor Detection of Endocrine Disrupting Compounds Using Engineered Estrogen Receptors
por: La Spina, Rita, et al.
Publicado: (2017)

Pesticides and SLE: Is the Link Estrogenic?
por: Tenenbaum, David J.
Publicado: (2005)

First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?
por: Wong, Z-W, et al.
Publicado: (2004)

Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
por: Ellis, Matthew J., et al.
Publicado: (2008)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy
por: Reinert, Tomás, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i63utbr7o7sa2p05igbbq4pfbj